GOG Foundation

 

Winter 2020 Symposium “It’s a PARP World After All”
10:32

GOG Foundation

PARPi Benefit in Ovarian Cancer: Does PARPi Maintenance Prolong PFS in Platinum Sensitive Disease? Are PARPi Mono Active in BRCA+ Relapsed Disease?

FEATURING Joyce Liu
  • 237 views
  • February 2, 2021
  • 2
09:08

GOG Foundation

Maintenance Therapy Clinical Trials in Newly Diagnosed Ovarian Cancer Are Positive for Prolonged PFS With BRCA Deriving the Most PFS Benefit

FEATURING Joyce Liu
  • 406 views
  • January 22, 2020
  • 3
05:55

GOG Foundation

Frontline Maintenance Therapy With PARPi is the Standard of Care in Ovarian Cancer

FEATURING Kathleen Moore
  • 505 views
  • January 22, 2020
  • 1
09:34

GOG Foundation

Clinically-Guided Interventions and New Clinical Trials Are Preferred Over Frontline PARPi Maintenance Therapy

FEATURING Michael Bookman
  • 79 views
  • January 22, 2020
03:01

GOG Foundation

Frontline Maintenance Therapy With PARPi is the Standard of Care in Ovarian Cancer: Why Is Rebuttal Even Needed?

FEATURING Kathleen Moore
  • 183 views
  • January 22, 2020
06:03

GOG Foundation

Expanding PARPi Horizons in Gynecological Cancers: Will Women With Endometrial Cancer Derive Benefit from Drugs Targeting DNA Repair?

FEATURING Bobbie J. Rimel
  • 58 views
  • January 22, 2020
08:20

GOG Foundation

Expanding PARPi Horizons in Gynecological Cancers: Cervical Cancer Clinical Trial Results and Future Proposals

FEATURING Ritu Salani
  • 19 views
  • January 22, 2020
16:52

GOG Foundation

Future of Clinical Trial Design in the New PARPi World in Gynecological Cancers: Biology Will Continue to Define New Hypothesis-Testing

FEATURING Robert Coleman
  • 33 views
  • January 22, 2020
  • 1
20:06

GOG Foundation

PARPi Monotherapy w/ Olaparib or Talazoparib Has Established Role as an Alternative to Chemotherapy for gBRCA and HER2- Metastatic Breast Cancer

FEATURING Charles Geyer
  • 388 views
  • January 22, 2020
  • 2
05:52

GOG Foundation

PARPi Are an Excellent Oral Option w/ Quick Time Response and Improves Quality of Life Compared to Chemo in Metastatic Breast Cancer

FEATURING Jennifer Litton
  • 491 views
  • January 22, 2020
10:11

GOG Foundation

Atezolizumab + nab-Paclitaxel Confers PFS/OS in PD-L1+ mTNBC as a New Standard of Care in 1st-Line Therapy

FEATURING Leisha Emens
  • 177 views
  • January 22, 2020
  • 1
24:23

GOG Foundation

PARPi as Monotherapy Have High-Level Anti-Tumor Activity in mCRPC w/ Identified Alterations in BRCA2 and Selected Other DNA Repair Genes

FEATURING Oliver Sartor
  • 155 views
  • January 22, 2020
  • 1
31:56

GOG Foundation

New Frontiers of PARPi Therapy in Pancreatic and Biliary Cancers: Tumor Profiling, Chemo for DDR-Defective Tumors, Mechanisms of PARPi Resistance

FEATURING James Abbruzzese
  • 414 views
  • January 22, 2020
  • 1